TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

FDA makes headway on product backlog

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

LO $43.53 +$0.14

at close on TUESDAY

Daily Photo Galleries

By The Associated Press
Wednesday, June 26, 2013, 12:01 a.m.
 

The Food and Drug Administration is taking a small step to whittle away a backlog of 4,000 tobacco product applications, some of which have lingered for more than two years.

The federal agency said Tuesday it has approved applications for two kinds of cigarettes sold by Lorillard Inc. They are two non-menthol versions of its flagship Newport brand.

The FDA said it has rejected four applications submitted to the agency for approval. It didn't say what they were.

A 2009 law gave the FDA authority to regulate tobacco. That included reviewing new products similar to those already being sold.

An Associated Press review in December found that the agency hadn't ruled on thousands of those applications for more than a year. The industry had expected a 90-day process.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Health insurers’ move towardd ‘high-value’ care providers may reduce choice
  2. Electric cars plug into solar power
  3. Pump prices: How low can you go? Below $3
  4. Pittsburgh-area stocks triumph over a volatile October
  5. Mark Phelan: Detroit 3 need to fix their troubled small cars
  6. US consumer spending down 0.2 percent in September
  7. Wal-Mart ups ante on holiday shopping
  8. Wall Street caps a wild month with a rally
  9. Coal official: Number of W.Va. mining sites falls to 96
  10. Under the Hood: Vibration problem needs 2nd set of eyes
  11. Roundup: WesBanco to acquire ESB Financial for $324M; PNC to replace credit cards used during Home Depot breach; more
Subscribe today! Click here for our subscription offers.